TY - JOUR
T1 - Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease model
AU - Jang, Geun C.
AU - Block, Peter C.
AU - Cowley, Michael J.
AU - Gruentzig, Andreas R.
AU - Dorros, Gerald
AU - Holmes, David R.
AU - Kent, Kenneth M.
AU - Leatherman, Louis L.
AU - Myler, Richard K.
AU - Sjolander, S. Matts E.
AU - Stertzer, Simon H.
AU - Vetrovec, George W.
AU - Willis, William H.
AU - Williams, David O.
PY - 1984/6/15
Y1 - 1984/6/15
N2 - A national study was carried out to determine the relative costs of PTCA and CABG. Baseline clinical criteria for the 2 groups were similar. Data were collected in 186 sets for the PTCA group and 175 sets for the CABG group. Male patients make up 81% of the PTCA group and 80% of the CABG group. Mean hospital stay was 12 ± 5 days in the CABG group, compared with 4 ± 2 days in the PTCA group (p < 0.001). The base charges for hospital and professional components of the CABG procedure were $15,580 ± $2,159, whereas the same charges for the PTCA procedure were $5,315 ± $2,159 (p < 0.001). With an 80% primary success rate, which was the group mean success rate, the average dollar savings per PTCA procedure would be $7,149, or $7,149,000 per 1,000 cases. Thus, PTCA for revascularization in 1-vessel CAD is significantly more cost-effective than CABG in the short term.
AB - A national study was carried out to determine the relative costs of PTCA and CABG. Baseline clinical criteria for the 2 groups were similar. Data were collected in 186 sets for the PTCA group and 175 sets for the CABG group. Male patients make up 81% of the PTCA group and 80% of the CABG group. Mean hospital stay was 12 ± 5 days in the CABG group, compared with 4 ± 2 days in the PTCA group (p < 0.001). The base charges for hospital and professional components of the CABG procedure were $15,580 ± $2,159, whereas the same charges for the PTCA procedure were $5,315 ± $2,159 (p < 0.001). With an 80% primary success rate, which was the group mean success rate, the average dollar savings per PTCA procedure would be $7,149, or $7,149,000 per 1,000 cases. Thus, PTCA for revascularization in 1-vessel CAD is significantly more cost-effective than CABG in the short term.
UR - http://www.scopus.com/inward/record.url?scp=0021251889&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021251889&partnerID=8YFLogxK
U2 - 10.1016/0002-9149(84)90746-X
DO - 10.1016/0002-9149(84)90746-X
M3 - Article
C2 - 6233888
AN - SCOPUS:0021251889
SN - 0002-9149
VL - 53
SP - C52-C55
JO - The American journal of cardiology
JF - The American journal of cardiology
IS - 12
ER -